Patients
Cancer
CELIAC, DISEASE, CANCER
Patients were eligible for inclusion in this prospective multicenter phase III trial if they met the following criteria: age 70 years or older, histopathologically confirmed ESCC, clinical stage II to III or clinical stage IV disease with metastatic lymph nodes in the supraclavicular or celiac trunk area (according to the sixth edition of the American Joint Committee on Cancer classification